Journal of Immunotherapy and Precision Oncology: 2023, vol: 6, issue: 2
1)- Juan I Ruiz, Maria A Lopez-Olivo, Yimin Geng, Maria E Suarez-Almazor. COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review.Journal of immunotherapy and precision oncology. 2023, 6 (2): 103-110
2)- Felipe Soto, Luis F Torre-Sada, Frank E Mott, Sang T Kim, Roza Nurieva, Vickie R Shannon, Saadia A Faiz, Roberto F Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature.Journal of immunotherapy and precision oncology. 2023, 6 (2): 111-116
3)- Khalid Balaraj. Abstracts Presented at the 2022 Emirates Oncology Conference: November 25-27, 2022, Abu Dhabi, United Arab Emirates.Journal of immunotherapy and precision oncology. 2023, 6 (2): 117-126
4)- Mirella Nardo, Deniz Can Guven, Aysun Senturk Yikilmaz, Shambhavi Singh, Jibran Ahmed. Learning From Failure: Negative Trials in Oncology.Journal of immunotherapy and precision oncology. 2023, 6 (2): 59-60
5)- Mauro Di Pilato, Yun Gao, Yi Sun, Amina Fu, Carina Grass, Thomas Seeholzer, Regina Feederle, Irina Mazo, Samuel W Kazer, Kevin Litchfield, Ulrich H von Andrian, Thorsten R Mempel, Russell W Jenkins, Daniel Krappmann, Peter Keller. Translational Studies Using the MALT1 Inhibitor ()-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.Journal of immunotherapy and precision oncology. 2023, 6 (2): 61-73
6)- Ian J Robertson, Timothy A Gregory, Steven G Waguespack, Marta Penas-Prado, Nazanin K Majd. Recent Therapeutic Advances in Pituitary Carcinoma.Journal of immunotherapy and precision oncology. 2023, 6 (2): 74-83
7)- Sebastian Brito-Orama, Rahul A Sheth. The Contemporary Landscape and Future Directions of Intratumoral Immunotherapy.Journal of immunotherapy and precision oncology. 2023, 6 (2): 84-90